comparemela.com

Latest Breaking News On - Ischemic cardiomyopathy - Page 3 : comparemela.com

Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials

Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas-smeenk
Heart-transplantation-program
Myocardial-regeneration-laboratory
Regulation-service-provider
Principal-investigator-of-the-research-institute
Circulatory-support-program
World-economic-forum-technology-pioneer-award
Hemostemix-inc
Mcgill-university
Alberta-newsfile-corp
Venture-exchange
Department-of-medicine

Hemostemix Inc.: Hemostemix Announces Presentation to the Emerging Growth Conference

Calgary, Alberta (Newsfile Corp. - October 25, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") invites shareholders, brokers and financial advisors, institutional investors

Canada
Canadian
Thomas-smeenk
World-economic-forum-technology-pioneer-award
Hemostemix-inc
Regulation-service-provider
Alberta-newsfile-corp
Venture-exchange
Emerging-growth-conference
Ischemic-cardiomyopathy
Critical-limb
Looking-information

Hemostemix Announces Presentation to the Emerging Growth Conference

Hemostemix Announces Presentation to the Emerging Growth Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas-smeenk
World-economic-forum-technology-pioneer-award
Hemostemix-inc
Regulation-service-provider
Alberta-newsfile-corp
Venture-exchange
Emerging-growth-conference
Ischemic-cardiomyopathy
Critical-limb

Hemostemix Inc.: Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market

Calgary, Alberta (Newsfile Corp. - October 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") and its wholly-owned subsidiary, PreCerv Inc., are pleased

Canada
Canadian
Thomas-smeenk
Thomas-abraham
World-economic-forum-technology-pioneer-award
Hemostemix-inc
Regulation-service-provider
Alberta-newsfile-corp
Venture-exchange
Precerv-inc
Global-data
Ischemic-cardiomyopathy

Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market

Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas-smeenk
Thomas-abraham
World-economic-forum-technology-pioneer-award
Hemostemix-inc
Regulation-service-provider
Alberta-newsfile-corp
Venture-exchange
Precerv-inc
Global-data
Ischemic-cardiomyopathy
Critical-limb
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.